- California had the worst job growth of any state.
- How Medicare pays providers: for the fiscal year that began on October 1, the new rule for hospital inpatient care is just short of 800 pages, with three columns of text for most of the published pages. The physician fee schedule and skilled nursing facilities rules for 2024 run 1227 and 147 pages, respectively.
- Other things equal, 3 psychological traits (competitiveness, risk tolerance, and confidence) lead to higher incomes.
- The Institute for Clinical and Economic Review determined that a cost-effective price for the newly approved gene therapy Lenmeldy is between $2.3M and $3.9M. Orchard Therapeutics, will be asking $4.25M.
- Why is colon cancer rising among young adults, but falling for seniors?
Category: Drug Prices & Regulations
Monday Links
- More young people are getting cancer.
- FDA gives up in its battle against ivermectin.
- Adultery is a crime in New York. (And you don’t get a jury trial.)
- US life expectancy is rising again. HT: Tyler.
- Future deficit spending may be worse than what the CBO is projecting.
- For the first time since the Black death, the world’s population is set to decline.
Saturday Links
- The U.S. is no longer among the top 20 happiest countries.
- Saving lives with pig kidneys.
- Why is fetal tissue research so controversial?
- Liberating the pharmacists.
- Highest drug price ever: $4.25 million per treatment.
- Site neutrality (same fee regardless of where the procedure is performed) would save Medicare more than $3.7 billion over the next decade, and lower beneficiary co-payments by $40 a visit.
Should Patient Assistance Programs Count Towards Your Deductible (should they even be legal?)
Demand curves are downward sloping. There I said it! It’s apparently controversial to many public health advocates and Members of Congress. All the while, supply curves slope upward. If you don’t know what I’m talking about you should not have slept through your Econ 101 class in college. You can boil this down to “people buy less when prices rise” and “incentives matter.”